| CAS ID: | 202138-50-9 |
| Molecular Formula: | C23H34N5O14P |
| Molecular Weight: | 519.5 g/mol |
| Monoisotopic Mass: | 519.173 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | PMPA | GS-4331-05 | PMPA PRODRUG | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | TENOFOVIR | GS-1278 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t14-;/m1./s1 | See All |
| InChI Key: | VCMJCVGFSROFHV-WZGZYPNHSA-N | |
| Smiles: | CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C.OC(=O)\C=C\C(=O)O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02224456 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Active, not recruiting |
| First Received | August 25, 2014 | Last Verified | February 28, 2018 |
| Sponsor | GlaxoSmithKline | ||
Trial Record 2
| ClinicalTrial ID | NCT01529749 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | February 9, 2012 | Last Verified | February 19, 2016 |
| Sponsor | Felipe Garcia | ||
| PubChem: | 6398764 |
| ChEMBL: | CHEMBL1486 |